Artemis Biosystems, Inc.

Cambridge, MA · Founded 2010 · CIK 0001491568 · Biotech · Private

VHU® Perfusion System for rapid viral vector and vaccine production at commercial scale

artemisbiosystems.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$50K
1 Form D · May 2010
197 months since last filing
Contracts
—
No federal contracts on record
Patents
3
2 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$50,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1230EZRABIO INC.——
1231Gaius Therapeutics, Inc,—$60K
1232SYNVIVIA, INC.—$54K
1233Artemis Biosystems, Inc.—$50K
1234Factor Medical, LLC—$50K
1235Auvi Labs, Inc.—$543K
1236CANGET BIOTEKPHARMA, LLC—$25K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 2 related persons
  • Maurizio CattaneoDirector · Executive Officer
  • Remco SpanjaardDirector

Patents

USPTO · 2 granted of 3

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.